TY - JOUR
T1 - Atrial Fibrillation Complicating Acute Myocardial Infarction
T2 - Prevalence, Impact, and Management Considerations
AU - Sadat, Besher
AU - Al Taii, Haider
AU - Sabayon, Muhie
AU - Narayanan, Chockalingam A.
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024/5
Y1 - 2024/5
N2 - Purpose of Review: Atrial fibrillation (AF) and myocardial infarction (MI) often coexist, and this overlapping nature leads to heightened morbidity and increases the need for comprehensive risk management strategies. The precise trajectory and implications of atrial fibrillation complicating myocardial infarction remain subjects of debate, with divergent reports presenting varying accounts. This review seeks to provide an in-depth exploration of the existing literature to cover the predictors, implication, and available management of new onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI). Recent Findings: Clinical risk factors, laboratory markers, echocardiographic findings, and angiographic data can be used to assess patients at risk of developing NOAF post-AMI. The diagnosis of NOAF post MI has been associated with overall worse short- and long-term prognosis with increased risk for mortality, cardiogenic shock, stroke, and bleeding, along with reduced rates of coronary angiography and percutaneous coronary intervention, and higher risk of future recurrence of AF and ischemic stroke. Summary: Despite the paucity of preventative treatment, the optimal management of acute coronary syndrome and the use of guideline directed therapy do decrease the risk of development of atrial fibrillation post myocardial infarction.
AB - Purpose of Review: Atrial fibrillation (AF) and myocardial infarction (MI) often coexist, and this overlapping nature leads to heightened morbidity and increases the need for comprehensive risk management strategies. The precise trajectory and implications of atrial fibrillation complicating myocardial infarction remain subjects of debate, with divergent reports presenting varying accounts. This review seeks to provide an in-depth exploration of the existing literature to cover the predictors, implication, and available management of new onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI). Recent Findings: Clinical risk factors, laboratory markers, echocardiographic findings, and angiographic data can be used to assess patients at risk of developing NOAF post-AMI. The diagnosis of NOAF post MI has been associated with overall worse short- and long-term prognosis with increased risk for mortality, cardiogenic shock, stroke, and bleeding, along with reduced rates of coronary angiography and percutaneous coronary intervention, and higher risk of future recurrence of AF and ischemic stroke. Summary: Despite the paucity of preventative treatment, the optimal management of acute coronary syndrome and the use of guideline directed therapy do decrease the risk of development of atrial fibrillation post myocardial infarction.
KW - Anticoagulation
KW - Atrial fibrillation
KW - Heart failure
KW - Myocardial infarction
KW - Percutaneous coronary intervention
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85187907908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85187907908&partnerID=8YFLogxK
U2 - 10.1007/s11886-024-02040-7
DO - 10.1007/s11886-024-02040-7
M3 - Article
C2 - 38483761
AN - SCOPUS:85187907908
SN - 1523-3782
VL - 26
SP - 313
EP - 323
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 5
ER -